Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Alves, Adelson"'
Autor:
Bellesso, Marcelo, Bianco, Alice, Santucci, Rodrigo, Centrone, Renato Torrescasana, Oliveira, Iohanã Gabriely Costa, Alves, Adelson
Publikováno v:
In Hematology, Transfusion and Cell Therapy April-June 2024 46(2):215-217
Publikováno v:
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 3, Pages: 382-384, Published: 18 OCT 2021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::9217972d799be17c833a888211c6ae51
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792021000300382&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792021000300382&lng=en&tlng=en
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Squassoni, Selma Denis, Sekiya, Eliseo Joji, Fiss, Elie, Lapa, Monica Silveira, Cayetano, Daniela dos Santos, Nascimento, Flávia, Alves, Adelson, Machado, Nadine Cristina, Escaramboni, Bruna, Lívero, Francislaine Aparecida dos Reis, Malagutti-Ferreira, Maria José, Soares, Murilo Racy, dos Santos Figueiredo, Francisco Winter, Kramer, Beatriz Kimberly Nath, Zago, Priscila Megda João Job, Ribeiro-Paes, João Tadeu
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
International Journal of Chronic Obstructive Pulmonary Disease
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
International Journal of Chronic Obstructive Pulmonary Disease
Background and Objectives Chronic obstructive pulmonary disease (COPD) is characterized by the destruction of alveolar walls, chronic inflammation and persistent respiratory symptoms. There is no curative clinical treatment for COPD. In this context,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0d5be589066f00dcc8b0e683b53695d
Autor:
Centrone, Renato Torrescasana *, Seguro, Fernanda S *, Bellesso, Marcelo *, Nardinelli, Luciana *, Bendit, Israel, Rocha, Vanderson *, Alves, Adelson *
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:12200-12201
Autor:
Bellesso, Marcelo *, Santucci, Rodrigo *, Centrone, Renato Torrescasana *, Dias, Daniela Ferreira *, Rodrigues, Mariana Nascimento Caiaffo *, Travassos, Luana Correa *, Oliveira, Iohanã Gabriely Costa *, Gomes, Tamyres Alves *, Espadas, Caroline Jorge *, Ferreira, Joyce Barreto Marques da Rosa *, Santucci, Bruno *, Alves, Adelson *
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:11972-11973
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Centrone, Renato *, Bellesso, Marcelo, Bonito, Debora, Dias, Daniela, Santucci, Rodrigo, Aranha, Milton, Alves, Adelson
Publikováno v:
In Hematology, Transfusion and Cell Therapy October-December 2020 42(4):373-375
Autor:
Alves, Adelson
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::1a10349fef9e54e0f86c2d2250003b7d
http://www.scielo.br/pdf/rbhh/v34n3/v34n3a18.pdf
http://www.scielo.br/pdf/rbhh/v34n3/v34n3a18.pdf
Autor:
Massumoto, Celso M., Pinheiro, Ronald F., Pinheiro Júnior, Edilson D., Baiocchi, Otávio C., Alves, Adelson
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia v.26 n.3 2004
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Volume: 26, Issue: 3, Pages: 218-220, Published: 2004
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Volume: 26, Issue: 3, Pages: 218-220, Published: 2004
Gemtuzumab Ozogamicin (Mylotarg®) targets leukemia cells expressing the CD 33 receptor by means of a monoclonal antibody conjugated to a cytotoxic agent, calicheamicin. It was approved for use in elderly patients with relapsed or refractory acute my
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fc563e0038f4302fd9e3cb146947816d
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000300013
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000300013